Recently, the 2021 International Market Briefing & Financial Analyst Briefing held in conjunction with the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo ended successfully in Atlanta, USA. ... Read More >

The ability to detect a tumor earlier, when it is smaller, reduces the impact of surgery and treatment, improving the prognosis for many patients. ... Read More >

During the pandemic, it has become evident that people with cardiovascular disease and obesity are at much higher risk of developing very severe, even fatal COVID-19 disease. Researchers at Karolinska Institutet have identified some metabolic processes that SARS-CoV-2 uses to att... Read More >

A new study has used a state-of-the-art blood test to track damage to the brain in people who have sustained traumatic brain injury (TBI). Read More >

Early in the COVID-19 pandemic, individuals with Alzheimer's disease were identified as being at increased risk of developing severe COVID-19. ... Read More >

Chinese startup Sansure Biotech on Sunday won the award for healthcare innovation at the G20 Innovation League, a competition between 100 startups from over 20 countries.... Read More >

Hologic has launched its Novodiag system in Europe. The Waltham, MA-based company inherited the automated molecular diagnostic solution for on-demand testing of infectious diseases and antimicrobial resistance when it acquired Mobidiag Oy for $795 million.... Read More >

Quidel announced Thursday that preliminary estimates for its third quarter revenues are expected to rise between 6 and 7 percent year over year on COVID-19 assay sales.... Read More >

PerkinElmer said on Thursday that the US Food and Drug Administration has granted Emergency Use Authorization for the firm's assay to detect SARS-CoV-2 and the flu. ... Read More >

On Sep. 29, 2021, ET Healthcare announced that it was granted the ST2 patent of Critical Care Diagnostics, Inc. (CCD). So far, 7 Chinese companies have been legally authorized to manufacture and / or sell ST2 reagent products ... Read More >